Great Lakes Retirement’s Unilever UL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
20,295
+2,810
+16% +$162K 0.11% 150
2026
Q1
$1.01M Buy
17,485
+1,657
+10% +$111K 0.1% 155
2025
Q4
$1.04M Buy
15,828
+264
+2% +$17.7K 0.11% 150
2025
Q3
$1.04M Buy
15,564
+917
+6% +$63.3K 0.11% 147
2025
Q2
$1.01M Buy
14,647
+436
+3% +$30.6K 0.12% 145
2025
Q1
$952K Sell
14,211
-278
-2% -$17.9K 0.12% 147
2024
Q4
$924K Sell
14,489
-331
-2% -$22.4K 0.12% 148
2024
Q3
$1.08M Sell
14,820
-27
-0.2% -$1.87K 0.14% 142
2024
Q2
$919K Sell
14,847
-4,882
-25% -$288K 0.13% 145
2024
Q1
$1.11M Sell
19,729
-494
-2% -$27.4K 0.16% 126
2023
Q4
$1.1M Sell
20,223
-671
-3% -$36.2K 0.18% 117
2023
Q3
$1.16M Sell
20,894
-999
-5% -$57.7K 0.21% 103
2023
Q2
$1.28M Sell
21,893
-136
-0.6% -$8.08K 0.23% 93
2023
Q1
$1.29M Buy
22,029
+7,767
+54% +$441K 0.24% 83
2022
Q4
$808K Buy
+14,262
New +$763K 0.21% 84

Other funds holding UL

Great Lakes Retirement's UL Position: Q2 2026 in Review

Great Lakes Retirement increased its Unilever (UL) stake by 16% in Q2 2026, buying an estimated $162K and bringing the position to 20,295 shares worth $1.22M. The position accounts for 0.11% of the portfolio, ranked #150.

Great Lakes Retirement first reported a position in UL in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.29M in Q1 2023. 509 funds tracked by Wall St. Rank hold UL as of Q2 2026.

  • Great Lakes Retirement held 20,295 shares of Unilever worth $1.22M as of Q2 2026.
  • Great Lakes Retirement bought 2,810 Unilever shares in Q2 2026, an estimated $162K.
  • Unilever made up 0.11% of Great Lakes Retirement's portfolio in Q2 2026, its #150 holding.
  • Great Lakes Retirement first reported a position in Unilever in Q4 2022 and has held it in 15 quarters since.
  • Great Lakes Retirement's Unilever position peaked at $1.29M in Q1 2023.
  • 509 funds tracked by Wall St. Rank held Unilever as of Q2 2026.

Based on Great Lakes Retirement's 13F filing for Q2 2026, filed 30 Jul 2026.